BIO Annual SG&A
$841.72 M
+$13.90 M+1.68%
31 December 2023
Summary:
As of January 21, 2025, BIO annual selling, general & administrative expenses is $841.72 million, with the most recent change of +$13.90 million (+1.68%) on December 31, 2023. During the last 3 years, it has risen by +$42.92 million (+5.37%). BIO annual SG&A is now -4.04% below its all-time high of $877.12 million, reached on December 31, 2021.BIO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Quarterly SG&A
$200.44 M
+$5.72 M+2.94%
30 September 2024
Summary:
As of January 21, 2025, BIO quarterly selling, general & administrative expenses is $200.44 million, with the most recent change of +$5.72 million (+2.94%) on September 30, 2024. Over the past year, it has dropped by -$759.00 thousand (-0.38%). BIO quarterly SG&A is now -11.25% below its all-time high of $225.85 million, reached on March 31, 2021.BIO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO TTM SG&A
$34.52 B
-$778.69 M-2.21%
30 September 2024
Summary:
As of January 21, 2025, BIO TTM selling, general & administrative expenses is $34.52 billion, with the most recent change of -$778.69 million (-2.21%) on September 30, 2024. Over the past year, it has increased by +$33.67 billion (+3976.09%). BIO TTM SG&A is now -30.98% below its all-time high of $877.12 million, reached on December 31, 2021.BIO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.7% | -0.4% | +3976.1% |
| 3 y3 years | +5.4% | -7.3% | +3853.3% |
| 5 y5 years | +0.8% | -0.6% | +4085.7% |
BIO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.0% | +1.7% | -11.1% | +2.9% | -31.0% | at low |
| 5 y | 5-year | -4.0% | +5.4% | -11.3% | +5.9% | -31.0% | +71.2% |
| alltime | all time | -4.0% | +1993.8% | -11.3% | +631.5% | -31.0% | >+9999.0% |
Bio-Rad Laboratories Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $200.44 M(+2.9%) | $817.19 M(-0.1%) |
| June 2024 | - | $194.72 M(-9.4%) | $817.95 M(-1.6%) |
| Mar 2024 | - | $214.88 M(+3.7%) | $831.05 M(-1.3%) |
| Dec 2023 | $841.72 M(+1.7%) | $207.15 M(+3.0%) | $841.72 M(-0.6%) |
| Sept 2023 | - | $201.20 M(-3.2%) | $846.80 M(-1.2%) |
| June 2023 | - | $207.82 M(-7.9%) | $856.72 M(+0.0%) |
| Mar 2023 | - | $225.55 M(+6.3%) | $856.69 M(+3.5%) |
| Dec 2022 | $827.83 M(-5.6%) | $212.23 M(+0.5%) | $827.83 M(-1.1%) |
| Sept 2022 | - | $211.11 M(+1.6%) | $837.29 M(-0.6%) |
| June 2022 | - | $207.79 M(+5.6%) | $842.33 M(-0.7%) |
| Mar 2022 | - | $196.69 M(-11.3%) | $847.96 M(-3.3%) |
| Dec 2021 | $877.12 M(+9.8%) | $221.69 M(+2.6%) | $877.12 M(+0.5%) |
| Sept 2021 | - | $216.15 M(+1.3%) | $873.11 M(+2.1%) |
| June 2021 | - | $213.43 M(-5.5%) | $855.12 M(+2.9%) |
| Mar 2021 | - | $225.85 M(+3.8%) | $830.96 M(+4.0%) |
| Dec 2020 | $798.80 M(-3.1%) | $217.68 M(+9.8%) | $798.80 M(+0.4%) |
| Sept 2020 | - | $198.16 M(+4.7%) | $795.28 M(-0.4%) |
| June 2020 | - | $189.26 M(-2.3%) | $798.74 M(-1.5%) |
| Mar 2020 | - | $193.69 M(-9.6%) | $810.74 M(-1.7%) |
| Dec 2019 | $824.63 M(-1.2%) | $214.16 M(+6.2%) | $824.63 M(+0.0%) |
| Sept 2019 | - | $201.62 M(+0.2%) | $824.49 M(+0.1%) |
| June 2019 | - | $201.26 M(-3.0%) | $824.07 M(-1.1%) |
| Mar 2019 | - | $207.58 M(-3.0%) | $833.23 M(-0.2%) |
| Dec 2018 | $834.78 M(+3.5%) | $214.03 M(+6.4%) | $834.78 M(+1.5%) |
| Sept 2018 | - | $201.20 M(-4.4%) | $822.48 M(+0.4%) |
| June 2018 | - | $210.43 M(+0.6%) | $819.45 M(-0.3%) |
| Mar 2018 | - | $209.13 M(+3.7%) | $821.52 M(+1.8%) |
| Dec 2017 | $806.79 M(-1.0%) | $201.73 M(+1.8%) | $806.79 M(-2.0%) |
| Sept 2017 | - | $198.17 M(-6.7%) | $823.05 M(-0.4%) |
| June 2017 | - | $212.49 M(+9.3%) | $826.34 M(+0.8%) |
| Mar 2017 | - | $194.40 M(-10.8%) | $819.38 M(+0.6%) |
| Dec 2016 | $814.70 M(+6.9%) | $217.99 M(+8.2%) | $814.70 M(+3.1%) |
| Sept 2016 | - | $201.45 M(-2.0%) | $789.85 M(+1.8%) |
| June 2016 | - | $205.54 M(+8.3%) | $775.84 M(+1.7%) |
| Mar 2016 | - | $189.72 M(-1.8%) | $763.15 M(+0.2%) |
| Dec 2015 | $761.99 M(-5.7%) | $193.15 M(+3.0%) | $761.99 M(-1.9%) |
| Sept 2015 | - | $187.44 M(-2.8%) | $776.38 M(-1.9%) |
| June 2015 | - | $192.84 M(+2.3%) | $791.49 M(-0.4%) |
| Mar 2015 | - | $188.56 M(-9.1%) | $794.48 M(-1.7%) |
| Dec 2014 | $808.20 M(+1.3%) | $207.54 M(+2.5%) | $808.20 M(-0.9%) |
| Sept 2014 | - | $202.55 M(+3.4%) | $815.25 M(+0.0%) |
| June 2014 | - | $195.84 M(-3.2%) | $814.93 M(+0.1%) |
| Mar 2014 | - | $202.28 M(-5.7%) | $814.43 M(+2.0%) |
| Dec 2013 | $798.07 M(+17.1%) | $214.58 M(+6.1%) | $798.07 M(+3.3%) |
| Sept 2013 | - | $202.24 M(+3.5%) | $772.35 M(+5.8%) |
| June 2013 | - | $195.33 M(+5.1%) | $730.25 M(+4.7%) |
| Mar 2013 | - | $185.92 M(-1.6%) | $697.17 M(+2.1%) |
| Dec 2012 | $681.78 M(-2.0%) | $188.87 M(+17.9%) | $682.55 M(+2.1%) |
| Sept 2012 | - | $160.13 M(-1.3%) | $668.30 M(-2.4%) |
| June 2012 | - | $162.26 M(-5.3%) | $685.03 M(-2.1%) |
| Mar 2012 | - | $171.29 M(-1.9%) | $699.51 M(+0.5%) |
| Dec 2011 | $695.98 M(+9.6%) | $174.61 M(-1.3%) | $695.98 M(-0.3%) |
| Sept 2011 | - | $176.87 M(+0.1%) | $698.04 M(+4.2%) |
| June 2011 | - | $176.74 M(+5.4%) | $669.83 M(+3.2%) |
| Mar 2011 | - | $167.76 M(-5.0%) | $649.36 M(+2.2%) |
| Dec 2010 | $635.21 M(+5.6%) | $176.67 M(+18.8%) | $635.21 M(+2.1%) |
| Sept 2010 | - | $148.65 M(-4.9%) | $622.40 M(-0.8%) |
| June 2010 | - | $156.27 M(+1.7%) | $627.37 M(+2.0%) |
| Mar 2010 | - | $153.62 M(-6.3%) | $614.77 M(+2.2%) |
| Dec 2009 | $601.47 M(+1.7%) | $163.86 M(+6.7%) | $601.47 M(+1.6%) |
| Sept 2009 | - | $153.62 M(+6.9%) | $592.10 M(+0.5%) |
| June 2009 | - | $143.67 M(+2.4%) | $589.00 M(-0.5%) |
| Mar 2009 | - | $140.31 M(-9.2%) | $591.96 M(+0.1%) |
| Dec 2008 | $591.30 M(+16.4%) | $154.50 M(+2.6%) | $591.30 M(-1.4%) |
| Sept 2008 | - | $150.52 M(+2.6%) | $599.80 M(+5.8%) |
| June 2008 | - | $146.63 M(+5.0%) | $566.97 M(+5.0%) |
| Mar 2008 | - | $139.66 M(-14.3%) | $539.88 M(+6.3%) |
| Dec 2007 | $507.98 M(+15.7%) | $162.99 M(+38.5%) | $507.98 M(+8.7%) |
| Sept 2007 | - | $117.69 M(-1.6%) | $467.45 M(+2.6%) |
| June 2007 | - | $119.55 M(+11.0%) | $455.71 M(+2.0%) |
| Mar 2007 | - | $107.75 M(-12.0%) | $446.63 M(+1.7%) |
| Dec 2006 | $438.95 M | $122.46 M(+15.6%) | $438.95 M(+3.0%) |
| Sept 2006 | - | $105.95 M(-4.1%) | $426.11 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2006 | - | $110.47 M(+10.4%) | $422.90 M(+1.5%) |
| Mar 2006 | - | $100.07 M(-8.7%) | $416.66 M(+0.1%) |
| Dec 2005 | $416.08 M(+10.0%) | $109.63 M(+6.7%) | $416.08 M(-0.3%) |
| Sept 2005 | - | $102.74 M(-1.4%) | $417.28 M(+3.1%) |
| June 2005 | - | $104.22 M(+4.7%) | $404.73 M(+3.6%) |
| Mar 2005 | - | $99.50 M(-10.2%) | $390.70 M(+3.3%) |
| Dec 2004 | $378.26 M(+19.1%) | $110.83 M(+22.9%) | $378.26 M(+6.7%) |
| Sept 2004 | - | $90.18 M(-0.0%) | $354.48 M(+3.5%) |
| June 2004 | - | $90.20 M(+3.6%) | $342.51 M(+4.0%) |
| Mar 2004 | - | $87.06 M(+0.0%) | $329.26 M(+3.1%) |
| Dec 2003 | $317.52 M(+12.8%) | $87.04 M(+11.3%) | $319.36 M(+4.6%) |
| Sept 2003 | - | $78.22 M(+1.7%) | $305.27 M(+1.6%) |
| June 2003 | - | $76.95 M(-0.3%) | $300.46 M(+2.5%) |
| Mar 2003 | - | $77.16 M(+5.8%) | $293.00 M(+4.1%) |
| Dec 2002 | $281.58 M(+3.3%) | $72.94 M(-0.6%) | $281.50 M(-1.6%) |
| Sept 2002 | - | $73.42 M(+5.7%) | $286.02 M(+2.2%) |
| June 2002 | - | $69.49 M(+5.8%) | $279.81 M(+1.5%) |
| Mar 2002 | - | $65.66 M(-15.2%) | $275.67 M(+1.1%) |
| Dec 2001 | $272.61 M(+10.1%) | $77.47 M(+15.3%) | $272.61 M(+6.4%) |
| Sept 2001 | - | $67.20 M(+2.8%) | $256.19 M(+2.9%) |
| June 2001 | - | $65.34 M(+4.4%) | $249.05 M(+0.5%) |
| Mar 2001 | - | $62.60 M(+2.5%) | $247.72 M(+0.0%) |
| Dec 2000 | $247.61 M(+23.6%) | $61.05 M(+1.6%) | $247.61 M(-4.2%) |
| Sept 2000 | - | $60.06 M(-6.2%) | $258.53 M(+6.8%) |
| June 2000 | - | $64.00 M(+2.4%) | $242.07 M(+10.1%) |
| Mar 2000 | - | $62.49 M(-13.2%) | $219.86 M(+9.7%) |
| Dec 1999 | $200.37 M(+15.9%) | $71.97 M(+65.1%) | $200.37 M(+12.8%) |
| Sept 1999 | - | $43.60 M(+4.3%) | $177.70 M(+1.5%) |
| June 1999 | - | $41.80 M(-2.8%) | $175.10 M(+0.2%) |
| Mar 1999 | - | $43.00 M(-12.8%) | $174.80 M(+1.1%) |
| Dec 1998 | $172.90 M(+4.9%) | $49.30 M(+20.2%) | $172.90 M(+3.4%) |
| Sept 1998 | - | $41.00 M(-1.2%) | $167.20 M(+0.7%) |
| June 1998 | - | $41.50 M(+1.0%) | $166.10 M(+0.6%) |
| Mar 1998 | - | $41.10 M(-5.7%) | $165.10 M(+0.2%) |
| Dec 1997 | $164.80 M(-16.7%) | $43.60 M(+9.3%) | $164.70 M(-19.7%) |
| Sept 1997 | - | $39.90 M(-1.5%) | $205.10 M(+1.3%) |
| June 1997 | - | $40.50 M(-0.5%) | $202.50 M(+0.9%) |
| Mar 1997 | - | $40.70 M(-51.5%) | $200.70 M(+1.5%) |
| Dec 1996 | $197.80 M(+31.6%) | $84.00 M(+125.2%) | $197.80 M(+28.4%) |
| Sept 1996 | - | $37.30 M(-3.6%) | $154.00 M(+0.7%) |
| June 1996 | - | $38.70 M(+2.4%) | $153.00 M(-0.1%) |
| Mar 1996 | - | $37.80 M(-6.0%) | $153.20 M(+1.9%) |
| Dec 1995 | $150.30 M(+13.3%) | $40.20 M(+10.7%) | $150.40 M(+3.1%) |
| Sept 1995 | - | $36.30 M(-6.7%) | $145.90 M(+2.3%) |
| June 1995 | - | $38.90 M(+11.1%) | $142.60 M(+4.9%) |
| Mar 1995 | - | $35.00 M(-2.0%) | $135.90 M(+2.5%) |
| Dec 1994 | $132.60 M(-20.7%) | $35.70 M(+8.2%) | $132.60 M(-6.0%) |
| Sept 1994 | - | $33.00 M(+2.5%) | $141.10 M(-4.7%) |
| June 1994 | - | $32.20 M(+1.6%) | $148.10 M(-6.1%) |
| Mar 1994 | - | $31.70 M(-28.3%) | $157.80 M(-5.7%) |
| Dec 1993 | $167.20 M(-5.9%) | $44.20 M(+10.5%) | $167.30 M(-0.4%) |
| Sept 1993 | - | $40.00 M(-4.5%) | $168.00 M(-1.1%) |
| June 1993 | - | $41.90 M(+1.7%) | $169.90 M(-5.0%) |
| Mar 1993 | - | $41.20 M(-8.2%) | $178.80 M(+0.7%) |
| Dec 1992 | $177.60 M(+15.1%) | $44.90 M(+7.2%) | $177.60 M(+1.8%) |
| Sept 1992 | - | $41.90 M(-17.5%) | $174.40 M(+2.4%) |
| June 1992 | - | $50.80 M(+27.0%) | $170.30 M(+8.1%) |
| Mar 1992 | - | $40.00 M(-4.1%) | $157.60 M(+2.1%) |
| Dec 1991 | $154.30 M(+11.2%) | $41.70 M(+10.3%) | $154.40 M(+3.3%) |
| Sept 1991 | - | $37.80 M(-0.8%) | $149.50 M(+2.3%) |
| June 1991 | - | $38.10 M(+3.5%) | $146.10 M(+2.0%) |
| Mar 1991 | - | $36.80 M(0.0%) | $143.30 M(+3.3%) |
| Dec 1990 | $138.70 M(+23.8%) | $36.80 M(+7.0%) | $138.70 M(+4.3%) |
| Sept 1990 | - | $34.40 M(-2.5%) | $133.00 M(+5.6%) |
| June 1990 | - | $35.30 M(+9.6%) | $126.00 M(+6.5%) |
| Mar 1990 | - | $32.20 M(+3.5%) | $118.30 M(+37.4%) |
| Dec 1989 | $112.00 M(+22.8%) | $31.10 M(+13.5%) | $86.10 M(+56.5%) |
| Sept 1989 | - | $27.40 M(-0.7%) | $55.00 M(+99.3%) |
| June 1989 | - | $27.60 M | $27.60 M |
| Dec 1988 | $91.20 M(+22.4%) | - | - |
| Dec 1987 | $74.50 M(+26.9%) | - | - |
| Dec 1986 | $58.70 M(+27.6%) | - | - |
| Dec 1985 | $46.00 M(+14.4%) | - | - |
| Dec 1984 | $40.20 M | - | - |
FAQ
- What is Bio-Rad Laboratories annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual SG&A year-on-year change?
- What is Bio-Rad Laboratories quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly SG&A year-on-year change?
- What is Bio-Rad Laboratories TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM SG&A year-on-year change?
What is Bio-Rad Laboratories annual selling, general & administrative expenses?
The current annual SG&A of BIO is $841.72 M
What is the all time high annual SG&A for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual selling, general & administrative expenses is $877.12 M
What is Bio-Rad Laboratories annual SG&A year-on-year change?
Over the past year, BIO annual selling, general & administrative expenses has changed by +$13.90 M (+1.68%)
What is Bio-Rad Laboratories quarterly selling, general & administrative expenses?
The current quarterly SG&A of BIO is $200.44 M
What is the all time high quarterly SG&A for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly selling, general & administrative expenses is $225.85 M
What is Bio-Rad Laboratories quarterly SG&A year-on-year change?
Over the past year, BIO quarterly selling, general & administrative expenses has changed by -$759.00 K (-0.38%)
What is Bio-Rad Laboratories TTM selling, general & administrative expenses?
The current TTM SG&A of BIO is $34.52 B
What is the all time high TTM SG&A for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM selling, general & administrative expenses is $877.12 M
What is Bio-Rad Laboratories TTM SG&A year-on-year change?
Over the past year, BIO TTM selling, general & administrative expenses has changed by +$33.67 B (+3976.09%)